European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
Top Cited Papers
Open Access
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 15 (9) , 1377-1399
- https://doi.org/10.1093/annonc/mdh301
Abstract
Germ cell tumour is the most frequent malignant tumour type in young men with a 100% rise in the incidence every 20 years. Despite this, the high sensitivity of germ cell tumours to platinum-based chemotherapy, together with radiation and surgical measures, leads to the high cure rate of ≥99% in early stages and 90%, 75-80% and 50% in advanced disease with ‘good’, ‘intermediate’ and ‘poor’ prognostic criteria (IGCCCG classification), respectively. The high cure rate in patients with limited metastatic disease allows the reduction of overall treatment load, and therefore less acute and long-term toxicity, e.g. organ sparing surgery for specific cases, reduced dose and treatment volume of irradiation or substitution of node dissection by surveillance or adjuvant chemotherapy according to the presence or absence of vascular invasion. Thus, different treatment options according to prognostic factors including histology, stage and patient factors and possibilities of the treating centre as well may be used to define the treatment strategy which is definitively chosen for an individual patient. However, this strategy of reduction of treatment load as well as the treatment itself require very high expertise of the treating physician with careful management and follow-up and thorough cooperation by the patient as well to maintain the high rate for cure. Treatment decisions must be based on the available evidence which has been the basis for this consensus guideline delivering a clear proposal for diagnostic and treatment measures in each stage of gonadal and extragonadal germ cell tumour and individual clinical situations. Since this guideline is based on the highest evidence level available today, a deviation from these proposals should be a rare and justified exception.Keywords
This publication has 223 references indexed in Scilit:
- A randomised trial of two radiotherapy schedules in the adjuvant treatment of stage I seminoma (MRC TE18)European Journal Of Cancer, 2001
- Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapseEuropean Journal Of Cancer, 2001
- Impact of cytotoxic treatment on long-term fertility in patients with germ-cell cancerInternational Journal of Cancer, 1999
- Radiotherapy after chemotherapy for metastatic seminoma—a diminishing roleEuropean Journal Of Cancer, 1997
- Surgery for a Post-Chemotherapy Residual Mass in SeminomaJournal of Urology, 1997
- Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage ISupportive Care in Cancer, 1996
- Cryopreservation of semen from adolescent patients with malignanciesMedical and Pediatric Oncology, 1996
- Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic diseaseEuropean Journal Of Cancer, 1993
- Low-dose radiation therapy for testicular intraepithelial neoplasiaZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Surveillance following orchidectomy for stage I seminoma of the testisEuropean Journal Of Cancer, 1993